Presentations held during the 1st hESCreg Symposium
On this page you find a detailed account of the presentations held during the Launch of hESCreg and the 1st European Human Embryonic Stem Cell Registry Symposium. All but one presenter consented to the publication of their presentations on this page. You can download individual presentations by clicking onto the respective links. The authors retain all relevant copyrights.
Friday, January 18, 2008
Launch of the European Human Embryonic Stem Cell Registry
Welcome
|
by Detlev Ganten, Charité, Germany |
hESC research and policy at the European level
|
by Octavi Quintana-Trias, European Commission, Belgium |
Quality assessment and the UK Stem Cell Bank
|
by Glyn Stacey, UK Stem Cell Bank, UK |
hESC features for registration and application
|
by Andreas Kurtz, BCRT, Germany |
Embryo and hESC characterization
|
by Anna Veiga, CMRB, Spain |
hESCreg Launch - Database and Website
|
by Joeri Borstlap, BCRT, Germany |
Session I: hESC Registries, Banks and International Harmonization
Chaired by Glyn Stacey
hESC-characterization projects of the International Stem Cell Forum: ISCI I and ISCI II
|
by Paul Gokhale, University of Sheffield, UK |
hESC registries and banks in the USA
|
by Derek Hei, WiCell, USA |
Current situation in the USA with respect to hESC research, regulation, institutes, networks, and cell-lines
|
by Susan Stayn, Stanford University, USA |
Embryonic stem cell research in Asia and the new Stem Cell Network of the Asia-Pacific region (SNAP)
|
by Doug Sipp, CDB Kobe, Japan |
Tools for hESC handling and cryobanking
|
by Günter Fuhr, Fraunhofer-Institute for Biomedical Technology, Germany |
hESC regulation in the UK
|
prepared by Peter Braude, King’s College London, UK, held by Paul de Sousa, University of Edinburgh, UK |
hESC regulation in Australia
|
by Anna Michalska, Monash University, Australia |
Saturday, January 19, 2008
Session II: hESC Application and Pathways to Therapy
Chaired by: Johan Hyllner
Mechanism of pluripotency in hESC
|
by Angel Raya, CMRB, Spain |
The path to application
|
by Johan Hyllner, Cellartis AB, Sweden |
Developmental toxicity testing using hESCs
|
16._Tina_Stumman_talk_abstract.pdf by Tina Stumman, ReProTect, JRC Ispra, Italy (abstract of talk) |
Session III: hESC Research in Europe
Chaired by: Outi Hovatta and Petr Dvorak
Current development of hESC research in the UK
|
by Paul de Sousa, University of Edinburgh, UK |
hESC research in Germany
|
by Peter Löser, Robert Koch Institute, Germany |
hESC research in France
|
by Carine Camby, Agence de la Biomedicine, France |
hESC research in Spain
|
by Victor González, Instituto de Salud Carlos III., Spain |
hESC research in Israel
|
by Benjamin Reubinoff, Hadassah University Hospital, Israel |
hESC research in Sweden
|
by Outi Hovatta, Karolinska Institutet, Sweden |
hESC registry and research in the Czech Republic
|
by Petr Dvorak, Masaryk University, Czech Republic |
hESC research in Finland
|
by Timo Tuuri, University of Helsinki, Finland |
hESC research in Switzerland
|
by Marisa Jaconi, Geneva University, Switzerland |
Stem-HD
|
by Marc Peschanski, INSERM, France |
Invitroheart
|
27._Carl-Fredrik_Mandenius.pdf Carl-Fredrik Mandenius, Linköping University, Sweden |
Crystal
by Jürgen Hescheler, University Cologne, Germany (this presentation will be available shortly)
Vitrocellomics
|
by Jörg Gerlach, University of Pittsburgh, USA |
Ethical topics regarding hESC research
|
byKlaus Tanner, Martin Luther University Halle-Wittenberg, Germany |


